Acta Chir Belg
-
Surgical resection of non-small cell lung cancer (NSCLC) is the treatment of choice if complete resection is possible. There is consensus regarding a pretreatment minimal staging. For the pre-operative exploration CT scan (with contrast) and mediastinoscopy are complemental. ⋯ A reported 7.5% 5-year survival was mainly for intrapulmonary metastases, also considered as satellite nodules. Careful follow-up of patients operated for lung cancer is necessary, as the incidence of metachronous lung cancer is as high as 10% for the long survivors. Reoperation with an economic but complete resection is the treatment of choice in the absence of metastases or other contraindications.